title: Anti-TNFalpha therapy in a rare case of Crohn's disease: still a panacea.
authors.forename: Robert
authors.initials: R
authors.lastname: Verburg
authors.forename: Pierre
authors.initials: P
authors.lastname: Zelissen
authors.forename: Aniki
authors.initials: A
authors.lastname: Rothova
authors.forename: Peter D
authors.initials: PD
authors.lastname: Siersema
authors.forename: Bas
authors.initials: B
authors.lastname: Oldenburg
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D004351:Drug Resistance; D006801:Humans; D000069285:Infliximab; D008297:Male; D010211:Papilledema / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014605:Uveitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab